Skip to main content

Table 1 Patient characteristics

From: Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma

Variable

No. of patients (%)

No. of patients

230 (100)

Age: Median [range], y

49 [13–78]

Gender

 

  Female

26 (11.3)

  Male

204 (88.7)

HBsAg

 

  Negative

15 (6.5)

  Positive

215 (93.5)

AFP: Median [range], ng/mL

157.3 [0.6-121000]

GGT: Median [range], U/l

45.0 [3.5-655.5]

Tumor size: Median [range], cm

4.6 [1.0-18.0]

Liver cirrhosis

 

  No

50 (21.7)

  Yes

180 (78.3)

Child-Pugh class

 

  A

225 (97.8)

  B

5 (2.2)

Tumor number

 

  Single

213 (92.6)

  Multiple

17 (7.4)

Satellite nodule

 

  No

199 (86.5)

  Yes

31 (13.5)

Tumor capsule

 

  No/incomplete

141 (61.3)

  Complete

89 (38.7)

Tumor differentiation

 

  I

14 (6.1)

  II

143 (62.2)

  III

66 (28.7)

  IV

7 (3.0)

Vascular invasion

 

  No

207 (90.0)

  Yes

23 (10.0)

TNM stage

 

  I

178 (77.4)

  II

11 (4.8)

  III

41 (17.8)

BCLC stage

 

  0

20 (8.7)

  A

106 (46.1)

  B

80 (34.8)

  C

24 (10.4)

Recurrence status

 

  No

105 (45.6)

  Early recurrence

85 (37.0)

  Late recurrence

40 (17.4)